Momenta Pharmaceuticals, Inc. (MNTA)

[Boing x 2]

floblu,

I hope all listen to the conference call. They were really upbeat. They are looking to have a subcue shot for over once a month approved at the same time.

For patients this will likely be a big plus vs. other company drugs.

My take from the CC is that they think they will be better than any other drug out there now and will less reactions and less shots. My words.

They are setting up M254 with these clinical trials at the same time along with the other indications.

Covid 19 was a big surprise and like they say they are ahead of the curve with all their other clinical trials on pancreatic cancer as their drug does not increase the bleeding like heparin does.

It is going to be a very interesting last six months of the year here as all these clinical trials come in during the last half of the year.

The great thing is the most investors still have not heard about our company.

Boing X 2